The founder of Insys Therapeutics Inc put profits over patient safety by bribing...
BOSTON - The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray, fueling the U.S. opioid epidemic, a federal prosecutor said on Thursday at the end of a landmark trial.
John Kapoor, the drugmaker’s former chairman, and four colleagues are the first executives of a painkiller manufacturer to face trial for conduct that authorities say was tied to a drug abuse epidemic that kills tens of thousands of Americans each year. Assistant U.S. Attorney Nathaniel Yeager told a federal jury in Boston in his closing argument that Kapoor sought to eliminate the risk of Insys failing after investing millions of dollars in founding it by bribing doctors to prescribe the company’s pain drug Subsys.
“They eliminated that risk and transferred it to the patients who were prescribed that drug,” Yeager said. “Profits over patients.”
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
Billionaire Los Angeles Times Owner Patrick Soon-Shiong Accused Of ‘Catch-And-Kill’ Scheme—With A Cancer DrugSorrento Therapeutics has accused billionaire Patrick Soon-Shiong of acquiring a cancer drug that would have competed with the blockbuster drug he invented and preventing it from ever reaching the market
और पढो »
House committee passes bills to strengthen Obamacare and lower drug pricesHouse Democrats are taking their first steps to fulfill their promises to strengthen Obamacare and lower drug prices, as the fate of the Affordable Care Act promises to be a major 2020 election issue.
और पढो »
2 drug giants are feuding over a highly successful new migraine drug, and court documents reveal how profitable the $10 billion market could beTwo drugmakers, Amgen and Novartis, have worked together for years on a new type of cutting-edge migraine drug, Aimovig.
और पढो »
U.S. to wrap case against drug company executives tied to opioid crisisProsecutors on Thursday will present their closing arguments in the trial of the...
और पढो »
FDA’s Gottlieb heads back to AEI to tackle drug pricesScott Gottlieb, the FDA commissioner who will step down Friday, plans to return to the American Enterprise Institute to write about and research drug prices.
और पढो »
With insulin price cap, drug industry is once again shamed into doing the right thingThe public and lawmakers have grown increasingly fed up with indefensibly high drug costs, and there’s a feeling among some policymakers that price controls should be on the table.
और पढो »
Ronald Siegel, drug expert who believed people naturally like to get high, dies at 76Ronald Siegel, a leading authority on psychoactive substances has died. An expert on paranoia and addiction, Siegel believed that in every human being nested a desire to get high. He was 76.
और पढो »
Biogen SMA drug price, Novartis estimates for its treatment far too high - U.S. groupBiogen Inc should slash the price of its spinal muscular atrophy (SMA) drug, and...
और पढो »
Walgreens cuts 2019 profit forecast, hit by lower drug pricesWalgreens Boots Alliance Inc shares fell 13 percent on Tuesday after the company...
और पढो »
Feds investigate Martin 'Pharma Bro' Shkreli for allegedly running a drug business from prisonFeds investigate 'Pharma Bro' Martin Shkreli for allegedly running a drug business from prison.
और पढो »